As of 2025-12-23, the Relative Valuation of Haemonetics Corp (HAE) is 102.85 USD. This relative valuation is based on P/E multiples. With the latest stock price at 80.34 USD, the upside of Haemonetics Corp based on Relative Valuation is 28.0%.
The range of the Relative Valuation is 80.32 - 126.47 USD.
| Range | Selected | |
| Trailing P/E multiples | 26.9x - 35.2x | 31.0x |
| Forward P/E multiples | 22.1x - 29.7x | 25.9x |
| Fair Price | 80.32 - 126.47 | 102.85 |
| Upside | -0.0% - 57.4% | 28.0% |
| Date | P/E |
| 2025-12-22 | 22.36 |
| 2025-12-19 | 22.32 |
| 2025-12-18 | 22.24 |
| 2025-12-17 | 22.26 |
| 2025-12-16 | 22.57 |
| 2025-12-15 | 22.38 |
| 2025-12-12 | 23.24 |
| 2025-12-11 | 23.50 |
| 2025-12-10 | 24.26 |
| 2025-12-09 | 23.33 |
| 2025-12-08 | 23.16 |
| 2025-12-05 | 23.36 |
| 2025-12-04 | 23.33 |
| 2025-12-03 | 22.80 |
| 2025-12-02 | 22.49 |
| 2025-12-01 | 22.53 |
| 2025-11-28 | 22.64 |
| 2025-11-26 | 22.47 |
| 2025-11-25 | 22.44 |
| 2025-11-24 | 22.17 |
| 2025-11-21 | 21.93 |
| 2025-11-20 | 20.91 |
| 2025-11-19 | 20.93 |
| 2025-11-18 | 20.71 |
| 2025-11-17 | 20.68 |
| 2025-11-14 | 20.45 |
| 2025-11-13 | 20.57 |
| 2025-11-12 | 20.35 |
| 2025-11-11 | 19.96 |
| 2025-11-10 | 19.62 |
| 2025-11-07 | 19.03 |
| 2025-11-06 | 18.68 |
| 2025-11-05 | 14.12 |
| 2025-11-04 | 14.02 |
| 2025-11-03 | 13.99 |
| 2025-10-31 | 13.92 |
| 2025-10-30 | 13.91 |
| 2025-10-29 | 13.76 |
| 2025-10-28 | 14.02 |
| 2025-10-27 | 14.25 |
| 2025-10-24 | 14.27 |
| 2025-10-23 | 14.29 |
| 2025-10-22 | 14.29 |
| 2025-10-21 | 14.25 |
| 2025-10-20 | 14.11 |
| 2025-10-17 | 13.99 |
| 2025-10-16 | 13.85 |
| 2025-10-15 | 13.52 |
| 2025-10-14 | 13.85 |
| 2025-10-13 | 13.98 |